To cite this paper use one of the standards below:
Tuberculosis (TB) represents a major challenge to public health. In the lungs, Mycobacterium tuberculosis (Mtb) infects macrophages and dendritic cells (DCs), which initiate the immune response. Mtb manipulates host lipid metabolism to survive and has triacylglycerol as a carbon source to persist in a latent state in the host. Thus, herein, we evaluated the functions of lipid droplets (LD) in DC activation and bacterial burden during mycobacterial infection. The involvement of diacylglycerol acyltransferase 1 (DGAT-1), a triacylglycerol synthesis enzyme, and the eicosanoid prostaglandin (PG) E2 were also investigated. DCs were differentiated from C57BL/6 bone marrow with GM-CSF and infected with BCG (MOI 5). BCG-infected DCs presented an increase in lipid droplets (LD), triacylglycerol (TAG), cholesterol ester (CE); and lipid-related and proinflammatory gene expression. To evaluate the role of TAG synthesis, BCG-infected DCs were treated with DGAT-1 inhibitor (A922550). DGAT1 inhibition reduced LDs accumulation, MHCII surface expression, the proinflammatory gene inos expression, and the secretion of IL-1beta, IL-10 and TNF-alpha in DCs infected by BCG. Interestingly, PGE2 secretion was also reduced by DGAT-1 inhibition on infected DCs. PGE2 is important to inflammatory response of TB and to T cells differentiation. Then, PGE2 was added to DCs and promoted an increased BCG burden, cytokines release and LDs accumulation in BCG infected-DCs. PGE2 treatment reverted DGAT1 inhibition effects in cytokines secretion, but failed to modulate LDs accumulation in DGAT1 inhibitor treated-DCs. Together, TAG synthesis by DGAT1 and the lipid mediator PGE2 are important to LDs formation and functions in the inflammatory response of DCs infected by mycobacteria. We intend to further investigate the role of lipid metabolism pathways in antigen presentation by Mtb-infected DCs, which may contribute to the comprehension of immune response of TB and the development of new therapies.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper